An altered gut microbiome in pre-eclampsia: cause or consequence
- PMID: 38774629
- PMCID: PMC11106424
- DOI: 10.3389/fcimb.2024.1352267
An altered gut microbiome in pre-eclampsia: cause or consequence
Abstract
Hypertensive disorders of pregnancy, including pre-eclampsia, are a leading cause of serious and debilitating complications that affect both the mother and the fetus. Despite the occurrence and the health implications of these disorders there is still relatively limited evidence on the molecular underpinnings of the pathophysiology. An area that has come to the fore with regard to its influence on health and disease is the microbiome. While there are several microbiome niches on and within the body, the distal end of the gut harbors the largest of these impacting on many different systems of the body including the central nervous system, the immune system, and the reproductive system. While the role of the microbiome in hypertensive disorders, including pre-eclampsia, has not been fully elucidated some studies have indicated that several of the symptoms of these disorders are linked to an altered gut microbiome. In this review, we examine both pre-eclampsia and microbiome literature to summarize the current knowledge on whether the microbiome drives the symptoms of pre-eclampsia or if the aberrant microbiome is a consequence of this condition. Despite the paucity of studies, obvious gut microbiome changes have been noted in women with pre-eclampsia and the individual symptoms associated with the condition. Yet further research is required to fully elucidate the role of the microbiome and the significance it plays in the development of the symptoms. Regardless of this, the literature highlights the potential for a microbiome targeted intervention such as dietary changes or prebiotic and probiotics to reduce the impact of some aspects of these disorders.
Keywords: diet-intervention; inflammation; microbiome; pre-eclampia; probiotics.
Copyright © 2024 Deady, McCarthy, Barron, McCarthy, O’Keeffe and O’Mahony.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11106424/bin/fcimb-14-1352267-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11106424/bin/fcimb-14-1352267-g002.gif)
Similar articles
-
The role of intestinal microbiota on pre-eclampsia: Systematic review and meta-analysis.Eur J Obstet Gynecol Reprod Biol. 2023 Dec;291:49-58. doi: 10.1016/j.ejogrb.2023.10.003. Epub 2023 Oct 2. Eur J Obstet Gynecol Reprod Biol. 2023. PMID: 37826991 Review.
-
Gut Microbiome Changes in Gestational Diabetes.Int J Mol Sci. 2022 Oct 25;23(21):12839. doi: 10.3390/ijms232112839. Int J Mol Sci. 2022. PMID: 36361626 Free PMC article. Review.
-
Probiotics for preventing gestational diabetes.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD009951. doi: 10.1002/14651858.CD009951.pub3. Cochrane Database Syst Rev. 2021. PMID: 33870484 Free PMC article.
-
Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation.Gut. 2020 Mar;69(3):513-522. doi: 10.1136/gutjnl-2019-319101. Epub 2020 Jan 3. Gut. 2020. PMID: 31900289
-
Prenatal and postnatal administration of prebiotics and probiotics.Semin Fetal Neonatal Med. 2017 Oct;22(5):284-289. doi: 10.1016/j.siny.2017.07.002. Epub 2017 Jul 15. Semin Fetal Neonatal Med. 2017. PMID: 28720399 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical